IndraLab
Statements
YOD1 inhibits NLRP3 inflammasome complex assembly. 6 / 6
|
6
reach
"These results demonstrated that YOD1 negatively regulated the NLRP3 inflammasome activation in a deubiquitinase activity-dependent manner and explored a novel function of YOD1.In summary, our study revealed one of the essential and original mechanisms by which YOD1 promoted sepsis-induced DIC, and proposed YOD1 as a priming therapeutic target for NLRP3-inflammasome dysregulation-mediated disorders."